Yarrow Posts 43c Q3 Loss Per Share, Holds $268.9M Cash
YARW sits 46% above its 52-week low of $12.385.
Summary
Yarrow reported a $9.7 million net loss for Q3 2026, or 43 cents a share, and finished the quarter with $268.9 million in cash. Research and development expenses for the quarter were $5.3 million. The cash position is the headline number here: it follows the September offering that raised roughly $172.5 million in gross proceeds and $161.8 million net after the underwriters' option was exercised, so the balance sheet is freshly funded. At a $170 million market cap, a $9.7 million quarterly loss against $268.9 million of cash means dilution risk is off the table for now and the story stays on pipeline execution rather than financing. The 8-K carrying these results was filed minutes before this wire item, so the numbers are already in the public domain. No revenue or guidance figures were included in the headline.
At the time of this announcement, YARW was trading at $18.05 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $170.4M. The 52-week trading range was $12.39 to $46.95. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Dow Jones Newswires.